Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing

Xing Chen1, Collin E M Brathwaite2,3,4, Alexander Barkan2

  • 1Department Pharmacy, Winthrop-University Hospital, Mineola, NY, USA.

Obesity Surgery
|August 14, 2016
PubMed
Abstract

Insights

A single 2-g cefazolin dose before bariatric surgery provides adequate protective levels against methicillin-sensitive Staphylococcus aureus (MSSA). This dose ensures sufficient antibiotic concentration in adipose tissue, eliminating the need for intraoperative redosing.

Area of Science:

  • Pharmacokinetics
  • Infectious Disease
  • Surgical Prophylaxis

Background:

  • Methicillin-sensitive Staphylococcus aureus (MSSA) is a primary pathogen in bariatric surgery infections.
  • Effective antibiotic prophylaxis is crucial to prevent surgical site infections.

Purpose of the Study:

  • To determine if a single 2-g intravenous (IV) bolus dose of cefazolin achieves protective antibiotic levels in adipose tissue for bariatric surgery.
  • To evaluate cefazolin's pharmacokinetic profile in patients undergoing gastric bypass or sleeve gastrectomy.

Main Methods:

  • A pharmacokinetic study involving 37 patients undergoing bariatric surgery.
  • Cefazolin concentrations were measured in serum and adipose tissue (subcutaneous and peri-gastric) via high-performance liquid chromatography.
  • Specimens were collected at incision and before skin closure.

Main Results:

  • Cefazolin penetration into adipose tissue was 6-8% of serum levels.
  • Despite lower tissue penetration, cefazolin concentrations in all adipose tissue samples exceeded the minimum inhibitory concentration (MIC) for MSSA.
  • The 2-g cefazolin dose maintained protective levels for an average of 4.8 hours.

Conclusions:

  • A single 2-g IV bolus of cefazolin given preoperatively is adequate for MSSA prophylaxis during bariatric surgery.
  • This dosage achieves protective adipose tissue levels for the typical duration of these procedures.
  • Higher doses (3-4 g) are unnecessary, and a single 2-g dose obviates the need for intraoperative redosing.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
330
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
961
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
308
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
397